Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
Objective: To assess the activity and toxicity of cisplatin and irinotecan alternating with docetaxel in patients with advanced non-small cell lung cancer (NSCLC). Material and Method: Eligibility included chemo-naïve stage IIIB with malignant effusion and stage IV NSCLC patients with measurable dis...
Saved in:
Main Authors: | Charoentum C., Thongprasert S., Chewasakulyong B., Euathrongchit J., Sorraritchingchai S., Munprakan S. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-37149053450&partnerID=40&md5=084d5a357dc486f92b8f7b40f356ff89 http://www.ncbi.nlm.nih.gov/pubmed/18181342 http://cmuir.cmu.ac.th/handle/6653943832/2115 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Chaiyut Charoentum, et al.
Published: (2018) -
A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018) -
Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients
by: Sorraritchingchai S., et al.
Published: (2014) -
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
by: Charoentum C., et al.
Published: (2014) -
Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014)